Related Research Articles
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body. It gives a binary result, high-risk or low-risk classification, and helps physicians determine whether or not a patient will benefit from chemotherapy. Women with a low risk result can safely forego chemotherapy without decreasing likelihood of disease free survival. MammaPrint is part of the personalized medicine portfolio marketed by Agendia.
Mary-Claire King is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits. She studies the interaction of genetics and environmental influences and their effects on human conditions such as breast and ovarian cancer, inherited deafness, schizophrenia, HIV, systemic lupus erythematosus and rheumatoid arthritis. She has been the American Cancer Society Professor of the Department of Genome Sciences and of Medical Genetics in the Department of Medicine at the University of Washington since 1995.
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.
Richard G. Pestell is an Australian American oncologist and endocrinologist who is Distinguished Professor, Translational Medical Research, and the President of the Pennsylvania Cancer and Regenerative Medicine Research Center at the Baruch S. Blumberg Institute. He was previously Executive Vice President of Thomas Jefferson University and Director of the Sidney Kimmel Cancer Center of Thomas Jefferson University. Pestell was appointed an Officer of the Order of Australia in the 2019 Queen's Birthday Honours for distinguished service to medicine and medical education.
Edith Marie Flanigen is a noted American chemist, known for her work on synthesis of emeralds, and later zeolites for molecular sieves at Union Carbide.
The European Inventor Award, are presented annually by the European Patent Office, sometimes supported by the respective Presidency of the Council of the European Union and by the European Commission, to inventors who have made a significant contribution to innovation, economy and society, predominantly in Europe. Inventions from all technological fields are considered for this award. The winners in each category are presented with an award shaped like a sail. There is no cash prize associated with the award, however there is a cash prize for all 3 of the Young Inventors Prize finalists.
Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome, and how their cells express their genes as proteins, applying molecular biology to medical testing. In medicine the technique is used to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients, and in agricultural biosecurity similarly to monitor crop- and livestock disease, estimate risk, and decide what quarantine measures must be taken.
Dario Carlo Altieri, M.D., is an American physician and scientist working as director of the National Cancer Institute-designated Ellen and Ronald Caplan Cancer Center at The Wistar Institute in Philadelphia. Since 2015, he has served as the President and Chief Executive Officer (CEO) of The Wistar Institute. In addition, he co-founded the Cancer Biology Training Consortium and the Pancreatic Cancer alliance in 2005.
Olimpia Salas Martínez is a professor and researcher at the Monterrey Institute of Technology and Higher Education, State of Mexico. Her work has been recognized with Level 2 membership in the Sistema Nacional de Investigadores of Mexico (2014).
Jane Visvader is a scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne, Australia. She is the joint head of the Breast Cancer Laboratory with Geoff Lindeman.
Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.
Katherine Koontz Sanford, also known as Katherine Sanford Mifflin, was an American biologist and cancer researcher who worked at the National Cancer Institute for nearly 50 years, serving as head of Laboratory of Cellular and Molecular Biology. In the 1940s she became the first person to successfully clone a mammalian cell in vitro, which allowed for more efficient means of creating pure strains of cells for study. She also developed the first laboratory test to distinguish people with Alzheimer's disease and people predisposed to cancer.
Valerie Speirs is a Professor of Molecular Oncology at the University of Aberdeen. Her research aims to identify biomarkers of breast cancer to inform diagnosis and treatment.
Thea D. Tlsty is an American pathologist and professor of pathology at the University of California, San Francisco (UCSF). She is known for her research in cancer biology and her involvement in the discovery of cells that may be at the origin of metaplastic cancer, an invasive form of breast cancer.
Nirmala "Nimmi" Ramanujam is the Robert W. Carr Professor of Biomedical Engineering, and a faculty member in the Global Health Institute and the Department of Pharmacology & Cell Biology at Duke University. She is the director of the Center of Global Women's Health Technologies (GWHT) and founder of Zenalux Biomedical Inc. and Calla Health. Ramanujam has spent the last two decades developing precision diagnostics and more recently precision therapeutics for breast and cervical cancer, with a focus on addressing global health disparities. She has more than 20 patents and over 150 publications for screening, diagnostic, and surgical applications, and has raised over $30M of funding to pursue these innovations through a variety of funding mechanisms, including NIH R01s and R21s, NIH Bioengineering Partnerships, NCI Academic Industry Partnerships, NIH Small Business grants and USAID funding. As the founding director of the Center for Global Women's Health Technologies at Duke University, she has developed a consortium of over 50+ partners including international academic institutions and hospitals, non-governmental organizations, ministries of health, and commercial partners; this consortium is working to ensure that the technologies developed at the center are adopted by cancer control programs in geographically and economically diverse healthcare settings.
Erika L. Pearce is an American immunologist. She is the Bloomberg Distinguished Professor at the Johns Hopkins University after serving as director and a scientific member at Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany. Her work investigates the connection between metabolism and immune cell function with a particular focus on the regulation of T-cells. In 2018, she was awarded the Leibniz Prize for her "outstanding work in metabolism and inflammation research."
Jose Russo is a senior member and professor at Fox Chase Cancer Center, director of both the Irma H Russo, MD- Breast Cancer Research Laboratory and the Environment Research Center at FCCC-Temple Health. He is also a professor of biochemistry at the Temple Medical School in Philadelphia and an adjunct professor in pathology and cell biology at Thomas Jefferson College of Medicine.
Kathleen R. Cho is an American gynecological surgical pathologist. She is a Professor of Pathology and Internal Medicine at Michigan Medicine.
Cornelis Joseph Maria Melief is a globally recognised immunology expert specialising in cancer immunology and immunotherapy, with special focus on therapeutic cancer vaccines. He is Emeritus Professor, former head of the Department of Immunohematology and Blood Transfusion at the Leiden University Medical Center, and Chief Scientific Officer at ISA Therapeutics in Netherlands. He is known for his work in the field of cancer immunology, devising new cancer therapies based on the activation of the patient’s own immune system.
Andrea Lynn Richardson is an American pathologist and physician-scientist specialized in the molecular pathology of breast cancer. She is the Peter and Judy Kovler Professor in Breast Cancer Research and an associate professor of pathology and oncology at the Johns Hopkins School of Medicine. Richardson runs a clinic at the Sibley Memorial Hospital.
References
- ↑ "Profile of Laura J. van 't Veer, PhD". University of San Francisco. Retrieved 2015-02-26.
- ↑ "PROF. DR. LAURA VAN 'T VEER". AGENDIA. Retrieved 2019-10-23.
- ↑ Beishon, Marc (May–June 2006). "Laura van 't Veer: the person behind personalised treatments" (PDF). Cancer World: 6–13. Retrieved 3 March 2015.
- ↑ "Patents by Inventor Laura J. Van't Veer". justia.com. justia. Retrieved 3 March 2015.
- ↑ "Standing Committees". American Association for Cancer Research. Retrieved 2019-10-23.
- ↑ "Appendix BSpeaker Biographical Sketches". National Academy of Sciences. Retrieved 2019-10-23.
- ↑ "Annual Harry and Edith Gladstein Visiting Professor Lecture Indiana University, School of Medicine, Department of Medicine". Indiana University. Retrieved 26 February 2015.
- ↑ "2020 Inductees". Giants of Cancer Care. Retrieved 2021-12-12.
